The new, full-range TECNIS Odyssey intraocular lens aims to reduce dependence on glasses, with strong performance in any ...

The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence., Bizz ...

My New York City practice has been a refractive-only practice for more than 25 years, offering the full range of FDA-approved ...

Enhancement coverage applies within 24 months of the original procedure for refractive and premium lens pathways. Beyond this ...

Johnson & Johnson (NYSE:JNJ) ranks among the best most active stocks to buy right now. On March 13, Johnson & Johnson ...

In this episode of “iOpeners” from Ophthalmology Times, host Nicole Bajic, MD, comprehensive ophthalmologist at the Cole Eye Institute, Cleveland Clinic, speaks with Emily Schehlein, MD, about efforts ...

The Conversation reports cataract surgery is safe and common, with over 90% achieving 20/20 vision, but patients need to ...

On March 19, Barclays raised its price recommendation on Johnson & Johnson (NYSE:JNJ) to $234 from $217. It kept an Equal ...

Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...

Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis® intraocular lens (IOL), strengthening its position as a disruptive solution in premium ...

South Africa’s prestigious theatre awards recognise Gcobolwethu Dlova for her exceptional role in the 2025 school production Radio City.

Keratoconus is a rare, progressive ophthalmic disorder characterized by changes to the cornea that result in significant ...